Sociodemographic patterns in pharmacy dispensing of medications for erectile dysfunction in Sweden.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 2, p. 209, doi. 10.1007/s00228-017-2361-9
- By:
- Publication type:
- Article
Works by Mulinari, Shai
Results: 45
1
2
Money, Money, Money? Politico-Moral Discourses of Stem Cell Research in a Grant Allocation Process.
- Published in:
- Science & Technology Studies, 2015, v. 28, n. 2, p. 53, doi. 10.23987/sts.55350
- By:
- Publication type:
- Article
3
Does Maternal Country of Birth Matter for Understanding Offspring’s Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0129362
- By:
- Publication type:
- Article
4
Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062609
- By:
- Publication type:
- Article
5
Categorical and anti-categorical approaches to US racial/ethnic groupings: revisiting the National 2009 H1N1 Flu Survey (NHFS).
- Published in:
- Critical Public Health, 2018, v. 28, n. 2, p. 177, doi. 10.1080/09581596.2017.1316831
- By:
- Publication type:
- Article
6
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
- Published in:
- 2016
- By:
- Publication type:
- journal article
7
Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation.
- Published in:
- PLoS Medicine, 2015, v. 12, n. 2, p. 1, doi. 10.1371/journal.pmed.1001785
- By:
- Publication type:
- Article
8
Sociologisk forskning om covid-19-pandemin - en introduktion.
- Published in:
- Sociologisk Forskning - Journal of the Swedish Sociological Association, 2021, v. 58, n. 1/2, p. 5, doi. 10.37062/sf.58.23216
- By:
- Publication type:
- Article
9
Sociologiska perspektiv på coronakrisen: Fyra sociologer om samhällets reaktion på covid-19.
- Published in:
- Sociologisk Forskning - Journal of the Swedish Sociological Association, 2020, v. 57, n. 1, p. 67, doi. 10.37062/sf.57.21539
- By:
- Publication type:
- Article
10
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews.
- Published in:
- 2017
- By:
- Publication type:
- journal article
11
Content and strength of conflict of interest policies at Scandinavian medical schools: a cross sectional study.
- Published in:
- BMC Medical Education, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12909-022-03881-y
- By:
- Publication type:
- Article
12
Pharmaceutical Industry Payments to Patient Organizations in Poland: Analysis of the Patterns, Evolution, and Structure of Connections.
- Published in:
- International Journal of Social Determinants of Health & Health Services, 2025, v. 55, n. 2, p. 199, doi. 10.1177/27551938241305995
- By:
- Publication type:
- Article
13
Let The Drugs Lead The Way! On the Unfolding of a Research Program in Psychiatry.
- Published in:
- Philosophy, Psychiatry & Psychology, 2018, v. 25, n. 4, p. 289, doi. 10.1353/ppp.2018.0040
- By:
- Publication type:
- Article
14
Explaining Biological Depression Theories.
- Published in:
- Philosophy, Psychiatry & Psychology, 2018, v. 25, n. 4, p. 309, doi. 10.1353/ppp.2018.0043
- By:
- Publication type:
- Article
15
Race in clinical trials in Sweden: How regulatory and medical standards in clinical research trump the post‐racial discourse.
- Published in:
- Sociology of Health & Illness, 2024, v. 46, n. 2, p. 315, doi. 10.1111/1467-9566.13709
- By:
- Publication type:
- Article
16
A 'patient–industry complex'? Investigating the financial dependency of UK patient organisations on drug company funding.
- Published in:
- Sociology of Health & Illness, 2022, v. 44, n. 1, p. 188, doi. 10.1111/1467-9566.13409
- By:
- Publication type:
- Article
17
Revisiting the pharmaceuticalisation of pandemic influenza using Lukes' framework of power.
- Published in:
- Sociology of Health & Illness, 2020, v. 42, n. 2, p. 327, doi. 10.1111/1467-9566.13006
- By:
- Publication type:
- Article
18
Regulating drug information in Europe: a pyrrhic victory for pharmaceutical industry critics?
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
19
Expression and regulation of Spätzle-processing enzyme in Drosophila
- Published in:
- FEBS Letters, 2006, v. 580, n. 22, p. 5406, doi. 10.1016/j.febslet.2006.09.009
- By:
- Publication type:
- Article
20
Testosterone prescribing in the population-a short social epidemiological analysis in Sweden.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2016, v. 25, n. 1, p. 11, doi. 10.1002/pds.3836
- By:
- Publication type:
- Article
21
Two-Thirds of Survey Respondents in Southern Sweden Used Complementary or Alternative Medicine in 2015.
- Published in:
- Complementary Medicine Research, 2017, v. 24, n. 5, p. 302, doi. 10.1159/000464442
- By:
- Publication type:
- Article
22
Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
- Published in:
- International Journal of Health Services, 2022, v. 52, n. 3, p. 347, doi. 10.1177/00207314221083871
- By:
- Publication type:
- Article
23
Rho-guanine nucleotide exchange factors during development.
- Published in:
- Small GTPases, 2010, v. 1, n. 1, p. 28, doi. 10.4161/sgtp.1.1.12672
- By:
- Publication type:
- Article
24
Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data.
- Published in:
- Clinical Epidemiology, 2018, v. 10, p. 1657, doi. 10.2147/CLEP.S178638
- By:
- Publication type:
- Article
25
Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self‐regulation within the European context.
- Published in:
- Regulation & Governance, 2025, v. 19, n. 1, p. 200, doi. 10.1111/rego.12609
- By:
- Publication type:
- Article
26
International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency.
- Published in:
- Globalization & Health, 2023, v. 19, n. 1, p. 1, doi. 10.1186/s12992-022-00902-9
- By:
- Publication type:
- Article
27
Correction: Content and strength of conflict of interest policies at scandinavian medical schools: a cross sectional study.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
28
Contemporary Epidemiology: A Review of Critical Discussions Within the Discipline and A Call for Further Dialogue with Social Theory.
- Published in:
- Sociology Compass, 2016, v. 10, n. 2, p. 153, doi. 10.1111/soc4.12345
- By:
- Publication type:
- Article
29
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules.
- Published in:
- Sociology Compass, 2016, v. 10, n. 1, p. 74, doi. 10.1111/soc4.12335
- By:
- Publication type:
- Article
30
Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database.
- Published in:
- PLoS ONE, 2023, v. 18, n. 11, p. 1, doi. 10.1371/journal.pone.0290022
- By:
- Publication type:
- Article
31
Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe.
- Published in:
- International Journal of Health Policy & Management, 2022, v. 11, n. 12, p. 2842, doi. 10.34172/ijhpm.2022.6575
- By:
- Publication type:
- Article
32
Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries.
- Published in:
- International Journal of Health Policy & Management, 2018, v. 7, n. 6, p. 504, doi. 10.15171/ijhpm.2018.20
- By:
- Publication type:
- Article
33
Conceptual unclarity about COVID-19 ethnic disparities in Sweden: Implications for public health policy.
- Published in:
- Health: An Interdisciplinary Journal for the Social Study of Health, Illness & Medicine, 2023, v. 27, n. 2, p. 186, doi. 10.1177/13634593221074866
- By:
- Publication type:
- Article
34
Monoamine Theories of Depression: Historical Impact on Biomedical Research.
- Published in:
- Journal of the History of the Neurosciences, 2012, v. 21, n. 4, p. 366, doi. 10.1080/0964704X.2011.623917
- By:
- Publication type:
- Article
35
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: multilevel analysis of discriminatory accuracy.
- Published in:
- Ethnicity & Health, 2016, v. 21, n. 6, p. 578, doi. 10.1080/13557858.2016.1143090
- By:
- Publication type:
- Article
36
Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0235021
- By:
- Publication type:
- Article
37
Continued cancer drug approvals in Japan and Europe after market withdrawal in the United States: A comparative study of accelerated approvals.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13879
- By:
- Publication type:
- Article
38
Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 6, p. e196253, doi. 10.1001/jamanetworkopen.2019.6253
- By:
- Publication type:
- Article
39
Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden.
- Published in:
- European Journal of Public Health, 2015, v. 25, n. 6, p. 911, doi. 10.1093/eurpub/ckv099
- By:
- Publication type:
- Article
40
Measures of discriminatory accuracy and categorizations in public health: a response to Allan Krasnik's editorial.
- Published in:
- European Journal of Public Health, 2015, v. 25, n. 6, p. 910, doi. 10.1093/eurpub/ckv209
- By:
- Publication type:
- Article
41
Drug company payments to General Practices in England: Cross-sectional and social network analysis.
- Published in:
- PLoS ONE, 2021, v. 16, n. 12, p. 1, doi. 10.1371/journal.pone.0261077
- By:
- Publication type:
- Article
42
The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning.
- Published in:
- Philosophy, Ethics & Humanities in Medicine, 2014, v. 9, p. 1, doi. 10.1186/1747-5341-9-14
- By:
- Publication type:
- Article
43
The specificity triad: notions of disease and therapeutic specificity in biomedical reasoning.
- Published in:
- 2014
- By:
- Publication type:
- journal article
44
Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny.
- Published in:
- 2018
- By:
- Publication type:
- Letter
45
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.
- Published in:
- Journal of Public Health, 2018, v. 40, n. 3, p. 646, doi. 10.1093/pubmed/fdx101
- By:
- Publication type:
- Article